Baicalein and Baicalein-loaded liposomes attenuate manganese-induced injury in the rat substantia nigra
BACKGROUND/OBJECTIVES: Manganese (Mn) can accumulate in the brain, damage the basal ganglia and cause Parkinsonian phenotypes. Baicalein (BA), a natural flavonoid, shows therapeutic promise driven by its antioxidant and anti-inflammatory properties. This study aimed to evaluate whether BA and baicalein-loaded liposomes (BA-LPs) reduce Mn-induced injury to the substantia nigra. METHODS: Sixty male Wistar rats were allocated into six groups: control, Mn (50 mg/kg), BA (30 mg/kg), BA-LPs, and Mn combined with either BA or BA-LPs. Treatments were administered intraperitoneally twice weekly for four weeks, with BA and BA-LP pretreatments one hour before Mn exposure. Markers of oxidative stress and antioxidant defence, glial and astrocyte presence, neuroinflammation, apoptosis, histopathological and ultrastructural damage, and tyrosine hydroxylase (TH) and dopamine levels in the substantia nigra were assessed. RESULTS: Mn exposure significantly disrupted redox homeostasis, evidenced by significantly reduced Nrf2, HO-1, SOD, CAT, and GPx expression and protein activities, and elevated malondialdehyde levels. Mn exposure increased microglial and astrocytic biomarkers, as shown by elevated Iba-1 and GFAP, and induced neuroinflammation with elevated TLR4, NF-κB, IL-1β, IL-6, TNF-α, NO, and iNOS expression and protein activities. Mn increased levels of caspases 3 and 8 and a Bax/Bcl-2 ratio indicative of elevated apoptosis. Mn treatment caused histopathological and ultrastructural damage, and reduced TH and dopamine levels. In the Mn + BA and Mn + BA-LPs co-treatments, markers of antioxidant defences were significantly restored, neuroinflammation reduced, apoptosis attenuated, and TH and dopamine levels partially restored. Histological and ultrastructural findings confirmed reduced cellular damage in neuronal tissue with BA and BA-LPs co-treatments. CONCLUSIONS: BA and BA delivered via liposomes reduce Mn-induced neurotoxicity, lowering markers of oxidative stress, neuroinflammation, apoptosis, and neurodegenerative injury, with effects typically more extensive in the BA-LPs group.
Authors
- Wayne Grant Carter (ORCID: https://orcid.org/0000-0003-1475-2476)
- Manal Said Fawzy (ORCID: https://orcid.org/0000-0003-1252-8403)
- Ayat Badr Al-Ghafari (ORCID: https://orcid.org/0000-0001-9156-4263)
- Gehad Elsaid Elshopakey (ORCID: https://orcid.org/0000-0003-2924-9670)
- Wesam Nofal (ORCID: https://orcid.org/0009-0009-1373-7638)
- Ahmad Najem Alshammari
- Ekramy M. Elmorsy
- Huda A. Al Doghaither
Institutions
- Northern Border University (SA)
- University of Nottingham (GB)
- Mansoura University (EG)
- King Abdulaziz University (SA)
- Royal Derby Hospital (GB)
Publication Details
- Journal
- PLoS ONE
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1371/journal.pone.0362801
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Northern Borders University